Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Recent research from the Simon Group has discovered an unexpected novel role that autophagy plays during the generation of neutrophils.

Within human bone marrow two million neutrophils are generated every second which require complex regulation and substantial bio-energy.   The mechanisms that govern these are not yet fully understood.

Researchers at the Kennedy Institute have found that autophagy can degrade lipid droplets in neutrophil precursors to generate the large amounts of molecular energy-currency (adenosine triphosphate) required to sustain differentiation. By breaking down lipid droplets into free fatty acids, autophagy fuels a respiration pathway in the mitochondria, the energy-producing factories of cells, to enable differentiation.

In line with this, researchers found defects in the autophagy pathway associated with acute myeloid leukaemia, a disease that is characterised by immature myeloid precursors which are blocked in their differentiation.

You can read the full article on Immunity

The next goal for the researchers is to test if we can exploit this autophagy pathway to overcome the differentiation block in myeloid leukemia.  

Find out more about the Simon Group.

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.